(Q77491810)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9796657%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9796657%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

C J Clancy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9796657%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

M H Nguyen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9796657%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9796657%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9796657%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9796657%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9796657%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

573-575

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9796657%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01708622

6 December 2019

exact match

0 references

cites work

In vitro evaluation of voriconazole against some clinically important fungi

1 reference

12 December 2020

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

1 reference

12 December 2020

In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species

1 reference

12 December 2020

In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates

1 reference

12 December 2020

The Emerging Role of Fusarium Infections in Patients with Cancer

1 reference

12 December 2020

Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi

1 reference

12 December 2020

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

1 reference

12 December 2020

Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis

1 reference

12 December 2020

In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens.

1 reference

12 December 2020

In vitro sensitivity of medically significant Fusarium species to various antimycotics.

1 reference

12 December 2020

Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species

1 reference

12 December 2020

Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.

1 reference

12 December 2020

In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection

1 reference

12 December 2020

Itraconazole resistance in Aspergillus fumigatus

1 reference

12 December 2020

Trichosporon beigelii, an emerging pathogen resistant to amphotericin B

1 reference

12 December 2020